FDA approves 1st drug to treat postpartum depression


Postpartum depression affects as many as 400,000 women in the United States every year, and on Tuesday, the Food and Drug Administration approved the first drug specifically created to treat the disorder.
Brexanolone, also known as Zulresso, is delivered intravenously. The infusion takes 60 hours, and during a clinical trial, most participants showed improvement within 24 hours of receiving the drug, reporting they still felt the effects 30 days later. Brexanolone contains a synthetic form of allopregnanolone, a derivative of progesterone, which increases during pregnancy and drops dramatically after giving birth. It is thought allopregnanolone could contribute to postpartum depression.
Women with postpartum depression often feel profound sadness, anxiety, or despair. Many are treated with antidepressants that take weeks to kick in or sometimes don't work at all, as they do not address the hormonal changes that happen during and after pregnancy. Each Zulresso infusion is expected to cost $20,000 to $35,000, NBC News reports, and it's unknown how much insurance will cover. Researchers said each patient will likely only need one infusion. It is expected the FDA will soon decide if the drug is safe for women to use while breastfeeding.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
The New York Times plays defense after publishing leaked Mamdani college application details
IN THE SPOTLIGHT The decision to publish details of Zohran Mamdani's Columbia University application has reignited simmering questions about sourcing and editorial guidelines
-
New tariffs set on 14 trading partners
Speed Read A new slate of tariffs will begin August 1 on imports from Japan, South Korea, Thailand and more
-
Book reviews: 'Buckley: The Life and the Revolution That Changed America' and 'How to Be Well: Navigating Our Self-Care Epidemic, One Dubious Cure at a Time'
Feature How William F. Buckley Jr brought charm to conservatism and a deep dive into the wellness craze
-
Ozempic and its brethren are running headlong into American dining and dieting culture
In the Spotlight Some restaurants are feeling the burn. So are beauty expectations.
-
Desert wellness in Scottsdale: the best of Arizona's Old West
The Week Recommends Boost body, mind and soul in this hub of healthy living
-
Shakespeare not an absent spouse, study proposes
speed read A letter fragment suggests that the Shakespeares lived together all along, says scholar Matthew Steggle
-
5 tips for decluttering to get you through spring cleaning and beyond
The Week Recommends Organizing your space does not have to be quite so stressful
-
Chiva-Som Hua Hin: Thailand's wellness pioneer is second to none
The Blend Resort celebrates 30 years as the least 'institutionalised' institution in the wellness world
-
New Mexico to investigate death of Gene Hackman, wife
speed read The Oscar-winning actor and his wife Betsy Arakawa were found dead in their home with no signs of foul play
-
Giant schnauzer wins top prize at Westminster show
Speed Read Monty won best in show at the 149th Westminster Kennel Club dog show